Screener
Neurocrine Biosciences NBIX Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's net debt?
- Neurocrine Biosciences (NBIX) reported net debt of $189M in Q1 2026.
- How has Neurocrine Biosciences's net debt changed year-over-year?
- Neurocrine Biosciences's net debt decreased by 35.1% year-over-year, from $291M to $189M.
- What is the long-term trend for Neurocrine Biosciences's net debt?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's net debt has grown at a 23.9% compound annual growth rate (CAGR), from -$85.6M to -$249.7M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Neurocrine Biosciences's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude